November 5 – 9, 2015 |Boston, MA, USA |28th EORTC-NCI-AACR Conference

 

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

 

EORTC AACR NCA Boston 2015  XenTech will be present at the prestigious EORTC-NCI-AACR symposium on molecular   targets and cancer therapies in Boston in early November, with some very interesting new insights and posters. Talk with us about new ways to use PDX for biomarkers identification (Poster 1) and new methods to represent even closer human tumor with PDX mouse models (Poster 2). Our scientists will be glad to meet you there:

 

Jean-Gabriel JUDDE – President and CSO

– Olivier DEAS – Head of cell Biology

Marie TAVERNIER – Study Director

 

 

 

Our business team, Léa CARRIGNON and Vanessa YVONNET, will also be attending this event.

Meet them at the Booth 506 and go see our posters!

 

Poster 1: Cell-Autonomous Activation of the Interferon/STAT1 Pathway in Response to Genotoxic Treatment

 

Poster 2: Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer predict efficacy of standard of care and experimental treatments in collaboration with Biomodels

 

More information on the Conference Web Site.